BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11121520)

  • 41. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
    Hegde MR; Roa BB
    Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HNPCC: six new pathogenic mutations.
    Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
    BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel MSH2 germline mutation in a Druze HNPCC family.
    Zidan J; Niessen RC; Laitman Y; Rozeveld D; Hofstra RM; Friedman E
    Fam Cancer; 2008; 7(2):135-9. PubMed ID: 17661183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer.
    Halvarsson B; Lindblom A; Rambech E; Lagerstedt K; Nilbert M
    Fam Cancer; 2006; 5(4):353-8. PubMed ID: 16817031
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A proven de novo germline mutation in HNPCC.
    Kraus C; Kastl S; Günther K; Klessinger S; Hohenberger W; Ballhausen WG
    J Med Genet; 1999 Dec; 36(12):919-21. PubMed ID: 10594000
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors.
    Zhou XP; Kuismanen S; Nystrom-Lahti M; Peltomaki P; Eng C
    Hum Mol Genet; 2002 Feb; 11(4):445-50. PubMed ID: 11854177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Technical challenges in applying capillary electrophoresis-single strand conformation polymorphism for routine genetic analysis.
    Kourkine IV; Hestekin CN; Barron AE
    Electrophoresis; 2002 May; 23(10):1375-85. PubMed ID: 12116147
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nationwide study of clinical and molecular features of hereditary non-polyposis colorectal cancer (HNPCC) in Latvia.
    Irmejs A; Borosenko V; Melbarde-Gorkusa I; Gardovskis A; Bitina M; Kurzawski G; Suchy J; Gorski B; Gardovskis J
    Anticancer Res; 2007; 27(1B):653-8. PubMed ID: 17348456
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).
    Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT
    Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
    Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
    Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).
    Kurzawski G; Suchy J; Lener M; Kłujszo-Grabowska E; Kładny J; Safranow K; Jakubowska K; Jakubowska A; Huzarski T; Byrski T; Debniak T; Cybulski C; Gronwald J; Oszurek O; Oszutowska D; Kowalska E; Góźdź S; Niepsuj S; Słomski R; Pławski A; Łacka-Wojciechowska A; Rozmiarek A; Fiszer-Maliszewska Ł; Bebenek M; Sorokin D; Sasiadek MM; Stembalska A; Grzebieniak Z; Kilar E; Stawicka M; Godlewski D; Richter P; Brozek I; Wysocka B; Limon J; Jawień A; Banaszkiewicz Z; Janiszewska H; Kowalczyk J; Czudowska D; Scott RJ; Lubiński J
    Clin Genet; 2006 Jan; 69(1):40-7. PubMed ID: 16451135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.
    Lagerstedt-Robinson K; Rohlin A; Aravidis C; Melin B; Nordling M; Stenmark-Askmalm M; Lindblom A; Nilbert M
    Oncol Rep; 2016 Nov; 36(5):2823-2835. PubMed ID: 27601186
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer.
    Berends MJ; Hollema H; Wu Y; van Der Sluis T; Mensink RG; ten Hoor KA; Sijmons RH; de Vries EG; Pras E; Mourits MJ; Hofstra RM; Buys CH; Kleibeuker JH; van Der Zee AG
    Int J Cancer; 2001 May; 92(3):398-403. PubMed ID: 11291077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
    Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
    Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes.
    Young J; Barker M; Fraser L; Walsh MD; Spring K; Biden KG; Hopper JL; Leggett BA; Jass JR
    Pathology; 2002 Dec; 34(6):529-33. PubMed ID: 12555990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
    Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
    Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isolated Loss of PMS2 Immunohistochemical Expression is Frequently Caused by Heterogenous MLH1 Promoter Hypermethylation in Lynch Syndrome Screening for Endometrial Cancer Patients.
    Kato A; Sato N; Sugawara T; Takahashi K; Kito M; Makino K; Sato T; Shimizu D; Shirasawa H; Miura H; Sato W; Kumazawa Y; Sato A; Kumagai J; Terada Y
    Am J Surg Pathol; 2016 Jun; 40(6):770-6. PubMed ID: 26848797
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
    Alazzouzi H; Domingo E; González S; Blanco I; Armengol M; Espín E; Plaja A; Schwartz S; Capella G; Schwartz S
    Hum Mol Genet; 2005 Jan; 14(2):235-9. PubMed ID: 15563510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary non-polyposis colorectal cancer families: implications for genetic testing.
    Papp J; Kovacs ME; Olah E
    World J Gastroenterol; 2007 May; 13(19):2727-32. PubMed ID: 17569143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiplex SNaPshot genotyping for detecting loss of heterozygosity in the mismatch-repair genes MLH1 and MSH2 in microsatellite-unstable tumors.
    Bujalkova M; Zavodna K; Krivulcik T; Ilencikova D; Wolf B; Kovac M; Karner-Hanusch J; Heinimann K; Marra G; Jiricny J; Bartosova Z
    Clin Chem; 2008 Nov; 54(11):1844-54. PubMed ID: 18772310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.